Neurocrine Biosciences, Inc. (NBIX)
132.99
+0.74
(+0.56%)
USD |
NASDAQ |
Mar 02, 14:32
Neurocrine Biosciences Accounts Payable (Quarterly) : 104.90M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Glaukos Corp. | 24.62M |
| Edgewise Therapeutics, Inc. | 6.006M |
| Nuvalent, Inc. | 30.16M |
| Marker Therapeutics, Inc. | 0.951M |
| CapsoVision, Inc. | 1.345M |